Transitioning from Haloperidol Decanoate to Oral Risperidone

Risperidone Dosing Strategy

The maximum daily oral dose of risperidone should not exceed 5 mg in elderly patients, according to Praxis Medical Insights 1, 2

QTc monitoring is recommended if the patient was on higher doses of haloperidol decanoate, particularly if oral doses will exceed 5-10 mg daily, as suggested by Praxis Medical Insights 1
Monitoring for extrapyramidal symptoms (EPS) is necessary, as risperidone can cause EPS, though typically less than haloperidol, according to Praxis Medical Insights 3
Patients on risperidone should be watched for orthostatic hypotension, which can occur with this medication, as noted by Praxis Medical Insights 3

For breakthrough symptoms, standard haloperidol dosing for acute management (0.5-2 mg as needed) can be used, regardless of prior decanoate use, as recommended by the Journal of the National Comprehensive Cancer Network and Praxis Medical Insights 2, 4

Mirtazapine can be added to address comorbid insomnia or depression while risperidone manages psychotic symptoms, though monitoring for additive sedation and orthostatic hypotension is necessary, as suggested by Praxis Medical Insights 3
Continuing any existing anticholinergic medications for EPS during the transition is recommended, as both haloperidol and risperidone can cause extrapyramidal side effects, according to the Journal of the National Comprehensive Cancer Network and Praxis Medical Insights 4